Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
BNP Paribas Exane Eaton (ETN): 'we revisited our model and conclude our DC revenue CAGR of >20% through 2030 is achievable'
September 12, 2025 10:02 AM EDTBNP Paribas Exane analyst Andrew Buscaglia reiterated an Outperform rating and $413.00 price target on Eaton (NYSE: ETN).
The analyst comments "We believe Oracle's remarkable backlog inflection this week illustrates the magnitude of growth potential that's still ahead for ETN (+). We expect a similar backlog... More
DA Davidson on Oracle (ORCL): 'We believe OpenAI will continue to be a key winner from the explosion of growth in AI'
September 11, 2025 11:19 AM EDTDA Davidson analyst Gil Luria reiterated a Neutral rating and $300.00 price target on Oracle (NYSE: ORCL).
The analyst comments "We believe OpenAI will continue to be a key winner from the explosion of growth in AI, especially as long as it continues to lead our model rankings. However, we believe it may be helpful to put this announcement in context: OpenAI is still organized as a not-for-profit, which is limiting its ability to take in the capital it raised in March. This transition is... More
